About this trial
In septic shock, dysregulated host responses to pathogens lead to cytokine storms that damage host tissues and organs, further contributing to the development of organ dysfunction and increased mortality. For sepsis, blood purification can remove inflammatory factors in sepsis by filtration or adsorption, so as to achieve the purpose of reducing inflammatory mediators in the body. However, there are few prospective randomized controlled studies in children. Therefore, this study intends to compare the efficacy and prognosis of different blood purifications on children with sepsis through randomized controlled studies, so as to provide a corresponding basis for the treatment of children with sepsis blood purification.
Eligibility criteria
Qualifiers
Meet the 2005 diagnostic criteria for sepsis
Age 29 days - 18 years old
Sepsis-induced dysfunction of more than one organ or abnormal tissue perfusion, or septic shock
Diagnosis < 48 hours
Disqualifiers
Inability to obtain an informed consent from the subject, family member or an authorized surrogate
Subject has end-stage renal disease and requires chronic dialysis
There is clinical support for non-septic shock
Subject has had chest compressions as part of cardiopulmonary resuscitation this hospitalization without immediate return to communicative state
Trial design
Treatments tested in this trial
- blood purification(CVVH)
- blood purification(TPE+CVVH)
- blood purification(HP+CVVH)
Treatment groups
Sponsors and collaborators
Children's Hospital of Fudan University
Lead sponsor
First Affiliated Hospital of Xinjiang Medical University
Collaborator
Shandong Provincial Hospital
Collaborator
Children's Hospital of Soochow University
Collaborator
Southern Medical University, China
Collaborator